Cogent Biosciences (COGT) Assets: 2017-2020
Historic Assets for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $250.9 million.
- Cogent Biosciences' Assets rose 53.99% to $215.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $215.4 million, marking a year-over-year increase of 53.99%. This contributed to the annual value of $250.9 million for FY2020, which is 407.69% up from last year.
- According to the latest figures from FY2020, Cogent Biosciences' Assets is $250.9 million, which was up 407.69% from $49.4 million recorded in FY2019.
- Cogent Biosciences' Assets' 5-year high stood at $250.9 million during FY2020, with a 5-year trough of $49.1 million in FY2017.
- Moreover, its 3-year median value for Assets was $85.9 million (2018), whereas its average is $128.8 million.
- Its Assets has fluctuated over the past 5 years, first plummeted by 42.48% in 2019, then spiked by 407.69% in 2020.
- Yearly analysis of 4 years shows Cogent Biosciences' Assets stood at $49.1 million in 2017, then spiked by 74.95% to $85.9 million in 2018, then slumped by 42.48% to $49.4 million in 2019, then surged by 407.69% to $250.9 million in 2020.